Postauthorization safety study of Clottafact ®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study

Vox Sanguinis,Volume 113, Issue 2, Page 120-127, February 2018.

Source: Vox Sanguinis - December 13, 2017 Category: Hematology Source Type: research